September 2010
Microwave-Assisted Brønsted Acidic Ionic Liquid-Promoted One-Pot Synthesis of
1233
Heterobicyclic Dihydropyrimidinones by a Three-Component Coupling of Cyclopentanone, Aldehydes, and Urea
Chartrain, M.; Ikemoto, N.; Roberg, C. M.; Taylor, C. S.; Li, W.;
Bills, G. F. PCT Int WO 9907695, 1999; (d) Sidler, D. R.; Larsen, R.
D.; Chartrain, M.; Ikemoto, N.; Roberg, C. M.; Taylor, C. S.; Li, W.;
Bills, G. F. Chem Abstr 1999, 130, 182478.
Typical procedure for the synthesis of 4-benzo[1,3]-
dioxol-5-yl-7-benzo[1,3]dioxol-5-ylmethylene-1,3,4,5,6,7-hexa-
hydrocyclopentapyrimidin-2-one (entry 10, Table 1). To a
mixture of piperonal (300 mg, 2 mmol), cyclopentanone (177
lL, 168 mg, 2 mmol), and urea (72 mg, 1.2 mmol) acidic ionic
liquid (39 mg, 5 mol %) was added. The mixture was irradiated
in a MW reactor (CEM, Discover) at 90ꢀC (250 W) for 5 min
as required to complete the reaction. The mixture, after being
cooled to room temperature was poured into crushed ice (20 g)
and stirred for 5–10 min. the solid separated was filtered under
suction (water aspirator), washed with ice-cold water (20 mL)
and then recrystallized from hot ethanol to afford pure product
(320 mg, 82%) as white powder. mp 253–255ꢀC; IR (KBr):
[5] (a) Bruce, M. A.; Pointdexter, G. S.; Johnson, G. PCT Int.
Appl. WO 9833791, 1998; (b) Bruce, M. A.; Pointdexter, G. S.; John-
son, G. Chem Abstr 1998, 129, 148989.
[6] Snider, B. B.; Shi, Z. J Org Chem 1993, 58, 3828.
[7] (a) Snider, B. B.; Chen, J.; Patil, A. D.; Freyer, A. Tetrahe-
dron Lett 1996, 37, 6977; (b) Patil, A. D.; Kumar, N. V.; Kokke, W.
C.; Bean, M. F.; Freyer, A. J.; De, B. C.; Mai, S.; Truneh, A.; Faulk-
ner, D. J.; Carte, B.; Breen, L.; Hertzberg, R. P.; Johnson, R. K.;
Westley, J. W.; Ports, B. C. M. J Org Chem 1995, 60, 1182.
[8] (a) Biginelli, P. Gazz Chem Ital 1893, 23, 360; (b) Bigi-
nelli, P. Ber 1891, 24, 2962.
1679, 1492, 1452, 1242 cmꢁ1 1H NMR (400 MHz, DMSO-
;
d6): d ¼ 8.61 (s, 1H), 7.07 (s, 1H), 6.87 (s, 3H), 6.79–6.71 (m,
3H), 6.52 (s, 1H), 5.98 (s, 4H), 5.04 (s, 1H), 2.76 (s, 2H), 2.76
(br, 1H), 2.48 (br, 1H); 13C NMR (100 MHz, DMSO-d6): d ¼
153.5, 147.9, 147.8, 146.9, 145.9, 137.9, 137.7, 136.3, 132.5,
122.6, 120.1, 118.1, 116.9, 108.9, 108.5, 107.8, 107.2, 101.4,
101.3, 57.4, 28.7, 28.6; Anal. Cald for C22H18N2O5: C, 67.69;
H, 4.65; N, 7.18. Found: C, 67.51; H, 4.54; N, 7.01.
[9] (a) Kappe, C. O. Acc Chem Res 2000, 33, 879; (b) Singh,
M.; Devi, N. S. J Org Chem 2009, 74, 3141.
[10] (a) Polshettiwar, V.; Varma, R. S. Acc Chem Res 2008, 41,
629; (b) Roberts, B. A.; Strauss, C. R. Acc Chem Res 2005, 38, 653;
(c) Kappe, C. O. Angew Chem Int Ed 2004, 43, 6250.
[11] (a) Ranu, B. C.; Hajra, A.; Dey, S. S.; Jana, U. Tetrahedron
2003, 59, 813; (b) Ranu, B. C.; Samanta, S.; Hajra, A. Synlett 2002,
987; (c) Ranu, B. C.; Hajra, A. Tetrahedron 2001, 57, 4767; (d) Ranu,
B. C.; Hajra, A.; Jana, U. Synlett 2000, 75; (e) Ranu, B. C.; Hajra, A.;
Jana, U. Tetrahedron Lett 2000, 41, 531; (f) Rahman, M.; Roy, A.;
Majee, A.; Hajra. A. J Chem Res 2009, 178; (g) Hajra, A.; Kundu, D.;
Majee, A. J Heterocyclic Chem 2009, 46, 1019.
The catalyst recovered for the aqueous layer was dried
under vacumn and reused for subsequent reactions.
Acknowledgments. A.H. is pleased to acknowledge the finan-
cial support from DST (Grant No. SR/FTP/CS-107/2006). A. M.
acknowledges financial support from CSIR (Grant No. 01(2251)/
08/EMR-II. M.R. thank Visva-Bharati for a fellowship.
[12] (a) Wasserschield, P.; Welton, T. In Ionic Liquid in Synthe-
sis; Wiley-VCH, Weinheim, Germany, 2008; (b) Cole, A. C.; Jensen, J.
L.; Ntai, I.; Tran, K. L. T.; Weaver, K. J.; Forbes, D. C.; Davis, J. H., Jr.
J Am Chem Soc 2002, 124, 5962; (c) Fang, D.; Zhou, X.-L.; Ye, Z. -W.;
Liu, Z.-L. Ind Eng Chem Res 2006, 45, 7982; (c) Leng, Y.; Wang, J.;
Zhu, D.; Ren, X.; Ge, H.; Shen, L. Angew Chem Int Ed 2009, 48, 168.
[13] El-Subbagh, H. I.; Abu-Zaid, S. M.; Mahran, M. A.; Badria,
F. A.; Al-Obaid, A. M. J Med Chem 2000, 43, 2915.
REFERENCES AND NOTES
[1] (a) Kappe, C. O. Tetrahedron 1993, 49, 6937; (b) Kappe, C.
O.; Fabian, W. M. F. Tetrahedron 1997, 53, 2803; (c) Kappe, C. O.
Eur J Med Chem 2000, 35, 1043.
[14] (a) Lorand, T.; Deli, J.; Szabo, D.; Foeldesi, A.; Zschunke,
A. Pharmazie 1985, 40, 536; (b) Elgemeie, G. E. H.; Attia, A. M. E.;
Alkabai, S. S. Nucleos Nucleot Nucl 2000, 19, 723.
[2] (a) Ronyar, G. C.; Kinball, S. D.; Beyer, B.; Cucinotta, G.;
Dimarco, J. D.; Gougoutas, J.; Hedberg, A.; Malley, M.; McCarthy, J.
P.; Zhang, R.; Moreland, S. J Med Chem 1995, 38, 119; (b) Aswal, K.
S.; Rovnyak, G. C.; Kinball, S. D.; Floyd, D. M.; Moreland, S.; Swan-
son, B. N.; Gougoutas, J. Z.; Schwartz, J.; Smillie, K. M.; Mallay, M.
F. J Med Chem 1990, 33, 2629.
[15] (a) El-Subbagh, H. I.; Abu-Zaid, S. M.; Mahran, M. A.;
Badria, F. A.; Al-Obaid, A. M. J Med Chem 2000, 43, 2915; (b) Lor-
and, T.; Deli, J.; Szabo, D.; Foeldesi, A.; Zschunke, A. Pharmazie
1985, 40, 536; (c) Hammam, A. E. G.; Sharaf, M. A.; El-Hafez, N. A.
A. Indian J Chem B 2001, 40, 213.
[3] (a) Atwal, K. S.; Swanson, B. N.; Unger, S. E.; Floyd, D. M.;
Moreland, S.; Hedberg, A.; O’Reilly, B. C. J Med Chem 1991, 34, 806;
(b) Grover, G. J.; Dzwonczyk, S.; McMullen, D. M.; Normadinam, C.
S.; Sleph, P. G.; Moreland, S. J. J Cardiovasc Pharmacol 1995, 26, 289.
[4] (a) Nagarathnam, D.; Wong, W. C.; Miao, S. W.; Patance,
M. A.; Gluchowski, C. PCT Int Appl WO 9717969, 1997; (b) Nagar-
athnam, D.; Wong, W. C.; Miao, S. W.; Patance, M. A.; Gluchowski,
C. Chem Abstr 1997, 127, 65783; (c) Sidler, D. R.; Larsen, R. D.;
[16] (a) Zhu, Y.; Huang, S.; Pan, Y. Eur J Org Chem 2005,
2354; (b) Zhang, H.; Zhou, Z.; Yao, Z.; Xu, F.; Shen, Q. Tetrahedron
Lett 2009, 50, 1622.
[17] (a) Ranu, B. C.; Hajra, A.; Jana, U. J Org Chem 2000, 65, 6270;
(b) Ranu, B. C.; Hajra, A.; Dey, S. S. Org Process Res Dev 2002, 6, 817; (c)
Kundu, S. K.; Majee, A.; Hajra, A. Indian J Chem B 2009, 48, 408.
[18] (a) Akbari, J.; Heydari, A. Tetrahedron Lett 2009, 50, 423;
(b) Du, Z.; Li, Z.; Deng, Y. Synth Commun 2005, 35, 1343.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet